Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Colorectal Neoplasms × Abituzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 1 Prostate Cancer Metastatic 1 Colorectal and Ovarian Cancer Patients With Liver Metastases 1 Colorectal Neoplasms 1

Interventions

Bevacizumab 112 Fluorouracil 97 Oxaliplatin 96 Leucovorin 95 Irinotecan 85 Capecitabine 73 Cetuximab 63 Panitumumab 42 pembrolizumab 36 regorafenib 28 Nivolumab 22 IFL protocol 21 Folfox protocol 21 trifluridine tipiracil drug combination 14 Radiotherapy 13 durvalumab 11 Gemcitabine 10 Celecoxib 9 tremelimumab 7 binimetinib 7 aflibercept 7 Drug Therapy 7 Disulfides 7 Cyclophosphamide 7 Trifluridine 6 Trastuzumab 6 Sunitinib 6 Immunoglobulin G 6 Colonoscopy 6 130-nm albumin-bound paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01008475 2016-03-30

POSEIDON

Merck KGaA, Darmstadt, Germany

Phase 1/2 Completed

232 enrolled 20 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡